Literature DB >> 15944033

Galanin modulates cholinergic neurotransmission in the heart.

Erica K Potter1, Margaret A Smith-White.   

Abstract

The role of galanin (Gal) in the modulation of cholinergic neurotransmission in the heart in wild-type (129 SvJ), and GALR1 knockout mice has been studied. The mice were anaesthetised and ventilated. Blood pressure (BP) and the increase in pulse interval evoked by stimulation of the vagus nerve (deltaPI) were recorded. Resting BP and PI were not different in control and GALR1-KO mice. In control mice an intravenous, bolus injection of Gal (0.8-13 nmol/kg; n = 4-6) attenuated the deltaPI, dose dependently from 33 +/- 7% to 78 +/- 9.5%. In GALR1-KO mice, Gal (0.8-13 nmol/kg) did not attenuate deltaPI at any dose (n = 3-4). In control mice intravenous, bolus injection of neuropeptide Y (NPY; 0.5-10 nmol/kg, n = 5-7) attenuated the deltaPI by 13 +/- 10% to 67 +/- 7% with a half time to recovery of 0.5-5 +/- 1 min. In control mice, following activation of the cardiac sympathetic nerve (10 Hz for 2 min; n = 3) the deltaPI was attenuated by 92 +/- 2% with a half time to recovery of 7 +/- 1 min. In control mice in the presence of the beta-adrenoceptor antagonist propranolol (1 mg/kg), and 1 micromol/kg BIIE0426 (an NPY Y2 receptor antagonist) the deltaPI was 57+/-3% with a half time to recovery of 2.5+/-0.5 min. In GALR1-KO mice, in the presence of propranolol and BIIE0426 there was no inhibition of deltaPI. In mice, it is proposed that both Gal and NPY contribute to the prolonged attenuation of parasympathetic slowing of the heart following activation of the cardiac sympathetic nerve.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944033     DOI: 10.1016/j.npep.2004.12.006

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  10 in total

1.  Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

Authors:  Eric N Alston; Diana C Parrish; Wohaib Hasan; Kevin Tharp; Laura Pahlmeyer; Beth A Habecker
Journal:  Neuropeptides       Date:  2010-10-28       Impact factor: 3.286

Review 2.  Brain to bone: What is the contribution of the brain to skeletal homeostasis?

Authors:  Anna Idelevich; Roland Baron
Journal:  Bone       Date:  2018-05-16       Impact factor: 4.398

Review 3.  Peripheral cardiac sympathetic hyperactivity in cardiovascular disease: role of neuropeptides.

Authors:  Julia Shanks; Neil Herring
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-04       Impact factor: 3.619

4.  Regulation of glucose and insulin release following acute and repeated treatment with the synthetic galanin analog NAX-5055.

Authors:  Sean P Flynn; H Steve White
Journal:  Neuropeptides       Date:  2015-01-21       Impact factor: 3.286

5.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

6.  Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: cardiovascular distribution and characteristics of the kisspeptin receptor.

Authors:  Janet J Maguire; Helen R Kirby; Emma J Mead; Rhoda E Kuc; Xavier d'Anglemont de Tassigny; William H Colledge; Anthony P Davenport
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

7.  The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.

Authors:  Neil Herring; James Cranley; Michael N Lokale; Dan Li; Julia Shanks; Eric N Alston; Beatrice M Girard; Emma Carter; Rodney L Parsons; Beth A Habecker; David J Paterson
Journal:  J Mol Cell Cardiol       Date:  2011-12-07       Impact factor: 5.000

Review 8.  Autonomic cardiac innervation: development and adult plasticity.

Authors:  Wohaib Hasan
Journal:  Organogenesis       Date:  2013-05-14       Impact factor: 2.500

Review 9.  Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments.

Authors:  Anais Audebrand; Laurent Désaubry; Canan G Nebigil
Journal:  Front Cardiovasc Med       Date:  2020-01-24

10.  The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade.

Authors:  Manish Kalla; Guoliang Hao; Nidi Tapoulal; Jakub Tomek; Kun Liu; Lavinia Woodward; Erica Dall'Armellina; Adrian P Banning; Robin P Choudhury; Stefan Neubauer; Rajesh K Kharbanda; Keith M Channon; Olujimi A Ajijola; Kalyanam Shivkumar; David J Paterson; Neil Herring
Journal:  Eur Heart J       Date:  2020-06-14       Impact factor: 35.855

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.